We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Over 25 years senior R&D management and discovery/development experience with CSO and corp dev positions at venture-backed companies Rincon Pharma, GreenFuel, and ERA Biotech. Dr. Heifetz began his industry career at Ciba-Geigy Biotechnology and held positions of increasing responsibility with Novartis (NYSE:NVS) and the Novartis Research Foundation, then transitioned to the global life sciences company Syngenta (NYSE:SYT) after its spinout from Novartis. At Syngenta he led world-wide R&D for Syngenta Biopharma and was head of consumer health at the Syngenta Torrey Mesa Research Institute prior to joining Diversa Corp (NASDAQ:DVSA) as a Fellow. Dr. Heifetz received BS, MS and PhD degrees from Duke University in genetics and biochemical engineering, and earned a certificate in innovation management from the Kenan-Flagler School of Business at UNC-Chapel Hill. He is an inventor on over 100 issued patents/published applications and author of multiple scientific publications.
This speaker's sessions: